Bio-sight Capital - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $92,548.47 -2.07%
Ethereum $3,332.08 -3.27%
BNB $613.96 -4.54%
Optimism $2.19 -4.81%
Arbitrum $0.86 -5.03%
Solana $231.22 -2.46%
Polygon $0.52 -6.18%
Cosmos $7.91 -1.46%
Avalanche $42.67 +1.23%

Bitcoin $92,548.47 -2.07%
Ethereum $3,332.08 -3.27%
BNB $613.96 -4.54%
Optimism $2.19 -4.81%
Arbitrum $0.86 -5.03%
Solana $231.22 -2.46%
Polygon $0.52 -6.18%
Cosmos $7.91 -1.46%
Avalanche $42.67 +1.23%

Bio-sight Capital

investment firm

Summary
Investments
Exits

About

Bio-sight Capital is a private investment firm focused on lab business and investment business.

Ibaraki,Osaka,Japan
http://www.bs-capital.co.jp

Highlights

Lead Investments

Details

Founded date: Jan 1, 2002
Operating Status: Active
Legal Name: Bio-sight Capital, Inc.
Also Known As: バイオ・サイト・キャピタル,Bio-Sight Capital Co., Ltd.
Investor Type: Venture Capital

Bio-sight Capital is a private investment firm focused on lab business and investment business.

Investments

Number of Investments

Number of Lead Investments

6

1

Bio-sight Capital has made 6 investments. Their most recent investment was on Aug 14, 2020, when FunPep raised ¥1.50B.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Aug 14, 2020 FunPep	Series Unknown	¥1.50B	Medical Device	—
Oct 5, 2018 FunPep	Series Unknown	¥460M	Medical Device	—
Dec 18, 2015 JTEC CORPORATION Japan	Series Unknown	¥148.48M	Manufacturing	—
Apr 10, 2015 FunPep	Series Unknown	¥25.60M	Medical Device	—
Jun 11, 2008 Gene Techno Science	Series Unknown	¥500.25M	Biopharma	—

Show More

Exits

Bio-sight Capital has had 2 exits. Bio-sight Capital most notable exits include JTEC CORPORATION Japan , Gene Techno Science

Date	Company Name	Exit Type	Industry
Feb 28, 2018	JTEC CORPORATION Japan	IPO	Manufacturing	Detail
Nov 30, 2012	Gene Techno Science	M&A	Biopharma	Detail